Last updated: 2026-09-12 01:17:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Abbott Laboratories (ABT) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $101,98, with a market capitalisation of $182,09B and a P/E ratio of 32,97. Over the past 52 weeks, its price has ranged from $81,97 to $137,49. This page covers its latest market performance, valuation, price trends and company information.
$182,09B | |
$104,15 | |
$142,60 | |
$31,64 | |
$103,36 | |
6,93M | |
11,02M | |
32,97 | |
$137,49 | |
$81,97 | |
2,38% | |
-- |
Abbott Laboratories (ABT) last closed at $103,36 as of 2026-09-11 23:51:00, unchanged from the previous close of $103,36.
During the latest regular trading session, ABT traded between $31,64 and $142,60, with a volume of 6,93M shares. The closing price was near the middle and near the middle of its 52-week range.
Over the past seven days, Abbott Laboratories (ABT) moved from $108,93 to $101,98, representing a decline of 6,38% ($6,95).
The stock traded between $101,53 and $113,91 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 7,68 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 36,0%
ABT is currently trading at $101,98, placing it 36,0% of the way from its 52-week low of $81,97 to its 52-week high of $137,49. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 115000 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Abbott Laboratories (ABT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.